866-997-4948(US-Canada Toll Free)

Ocular Drug Delivery Technology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Published By :

Transparency Market Research

Published Date : Jul 2017

Category :

Biotechnology

No. of Pages : 214 Pages

Ocular Drug Delivery Technology Market: Overview

This report on the Global Ocular Drug Delivery Technology market analyzes the current and future scenario of the global market. Rise in private and public funding for R&D of novel drug delivery technologies, increase in prevalence of macular degeneration & diabetic retinopathy, and favorable regulatory scenario for introduction of innovative technologies are boosting the growth of the Global Ocular Drug Delivery Technology market. Rising demand for targeted drug delivery to the affected ocular tissue, and elimination of drug due to nasolacrimal drainage system when administered via topical route are some of the factors expected to drive the growth of Global Ocular Drug Delivery Technology market during the forecast period. 

The Ocular Drug Delivery Technology report comprises an elaborate executive summary, which includes market snapshot that provides information about various segments. It also provides information and data analysis of the global market with respect to the segments based on technology type, formulation type, disease type, end user, and geography. A detailed qualitative analysis of drivers and restraints, and opportunities has been provided in the market overview section. Additionally, the section comprises Porter’s Five Forces Analysis to help understand the competitive landscape in the market. This section also provides market attractiveness analysis in terms of geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the Global Ocular Drug Delivery Technology market. 

Ocular Drug Delivery Technology Market: Segmentation 

Based on the technology, the Ocular Drug Delivery Technology market has been segmented into 6 types, which are Topical, Ocular Inserts, Intraocular Implants, Iontophoresis, In Situ gel & Punctal Plugs, and Others. Ocular Inserts are further divided into Erodible & Non-erodible types, while Intraocular Implants are classified into Biodegradable & Non-biodegradable types. Intraocular Implants & Topical are considered to be leading segments of Ocular Drug Delivery Technology market, owing to the high patient compliance. They are expected to continue to dominate the market in terms of revenue by 2025, which is attributed to the introduction of novel drug delivery techniques by key players in the market. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. 

Different types of formulation types in the ocular drug delivery technology market are Solution, Suspension, Ointment, Emulsion, and Liposomes & Nanoparticles. Solutions accounted for highest market revenue in 2016, and is expected to remain leading in terms of revenue during the forecast period. The dominance is attributed to the introduction of preservative free formulation types & contamination free containers. 

Based on disease type, the global ocular drug delivery technology market is segmented into 7 major segments, which are Glaucoma, Macular Degeneration, Diabetic Retinopathy, Diabetic Macular Edema, Cataract, Dry Eye Syndrome, and Others. Macular Degeneration is anticipated to lead the market during the forecast period, owing to its high prevalence and government participation in spreading awareness for visual loss & blindness. 

Different types of end users are present in the Ocular Drug Delivery Technology are Hospitals, Ambulatory Surgical Centers, Ophthalmic Clinics, and Homecare Settings. Under the end user segment, Hospitals accounted for the largest share of the Global Ocular Drug Delivery Technology market in 2016, while Ophthalmic Clinics & Ambulatory Surgical Centers are expected to witness highest CAGR during 2017-2025. 

Ocular Drug Delivery Technology Market: Regional Analysis

Geographically, the global Ocular Drug Delivery Technology has been categorized into five major regions and the key countries in the respective region: North America (U.S. and Canada), Europe (U.K., Germany, France, Spain, Italy, Russia and Rest of Europe), Asia Pacific (India, Japan, China, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa). 

Ocular Drug Delivery Technology Market: Competitive Analysis 

The report also profiles major players in the Global Ocular Drug Delivery Technology based on various attributes such as company overview, financial overview, product portfolio, business strategies, SWOT analysis, and recent developments. Major players profiled in this report include OCULAR THERAPEUTIX, INC., Alimera Sciences, Allergan, Plc., Valeant Pharmaceuticals International, Inc. (Bausch & Lomb Incorporated), EyeGate Pharma, Envisia Therapeutics, Clearside Biomedical, INC., Graybug Vision Inc., Santen Pharmaceutical Co., Ltd, Taiwan Liposome Company, Ltd, and others. 

The Global Ocular Drug Delivery Technology Market has been segmented as given below: 

Global Ocular Drug Delivery Technology Market, by Technology, 

  • Topical
  • Ocular Insert
  • Erodible
  • Non-Erodible
  • Iontophoresis
  • Intraocular Implants
  • Biodegradable
  • Non-Biodegradable
  • In Situ Gel & Punctal Plugs
  • Others 

Global Ocular Drug Delivery Technology Market, by Formulation Type,

  • Solution
  • Suspension
  • Emulsion
  • Liposomes & Nanoparticles
  • Ointment

Global Ocular Drug Delivery Technology Market, by Disease Type,

  • Glaucoma
  • Macular Degeneration
  • Diabetic Retinopathy
  • Cataract
  • Diabetic Macular Edema
  • Dry Eye Syndrome
  • Others

Global Ocular Drug Delivery Technology Market, by End user

  • Hospitals
  • Ambulatory Surgical centers
  • Ophthalmic Clinics
  • Homecare Settings

Global Ocular Drug Delivery Technology Market, by Region

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Table of Content

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Ocular Drug Delivery Disease Type Market

4. Market Overview
4.1. Introduction
4.1.1. Disease Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Key Market Indicators
4.3.1. Region/Country Specific
4.3.2. Product/Application/Disease Type Specific
4.3.3. Target Market Specific – Global Scenario
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunity
4.5. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, 2015–2025
4.6. Ocular Drug Delivery Disease Type Market - Global Supply Demand Scenario
4.7. Porter’s Five Force Analysis
4.8. Market Outlook
4.9. Ocular Drug Delivery Technology: Pipeline Analysis

5. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By Disease Type
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Key Trends
5.4. Market Value Forecast By Disease Type , 2015–2025
5.4.1. Topical
5.4.2. Ocular Insert
5.4.2.1. Erodible
5.4.2.2. Non-Erodible
5.4.3. Iontophoresis
5.4.4. Intraocular Implant
5.4.4.1. Biodegradable
5.4.4.2. Non-Biodegradable
5.4.5. In Situ Gel & Punctal Plug
5.4.6. Others
5.5. Market Attractiveness By Disease Type

6. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By Formulation Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Key Trends
6.4. Market Value Forecast By Formulation Type , 2015–2025
6.4.1. Solution
6.4.2. Suspension
6.4.3. Emulsion
6.4.4. Liposomes & Nanoparticles
6.4.5. Ointments
6.5. Market Attractiveness By Formulation Type

7. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By Disease Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Key Trends
7.4. Market Value Forecast By Disease Type , 2015–2025
7.4.1. Diabetic Retinopathy
7.4.2. Macular Degeneration
7.4.3. Cataract
7.4.4. Glaucoma
7.4.5. Diabetic Macular Edema
7.4.6. Dry Eye Syndrome
7.4.7. Others
7.5. Market Attractiveness By Disease Type

8. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By End User
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Key Trends
8.4. Market Value Forecast By End User , 2015–2025
8.4.1. Hospitals
8.4.2. Ambulatory Surgical Centers
8.4.3. Ophthalmic Clinics
8.4.4. Homecare Settings
8.5. Market Attractiveness By End User

9. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By Region
9.1. Key Findings
9.2. Policies and Regulations
9.3. Market Value Forecast By Region
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East & Africa
9.4. Market Attractiveness By Country/Region

10. North America Ocular Drug Delivery Disease Type Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.1.2. Policies and Regulations
10.1.3. Price Trend Analysis
10.1.4. Key Trends
10.2. Market Value Forecast By Disease Type , 2015–2025
10.2.1. Topical
10.2.2. Ocular Insert
10.2.2.1. Erodible
10.2.2.2. Non-Erodible
10.2.3. Iontophoresis
10.2.4. Intraocular Implant
10.2.4.1. Biodegradable
10.2.4.2. Non-Biodegradable
10.2.5. In Situ Gel & Punctal Plug
10.2.6. Others
10.3. Market Value Forecast By Formulation Type , 2015–2025
10.3.1. Solution
10.3.2. Suspension
10.3.3. Emulsion
10.3.4. Liposomes & Nanoparticles
10.3.5. Ointments
10.4. Market Value Forecast By Disease Type , 2015–2025
10.4.1. Diabetic Retinopathy
10.4.2. Macular Degeneration
10.4.3. Cataract
10.4.4. Glaucoma
10.4.5. Diabetic Macular Edema
10.4.6. Dry Eye Syndrome
10.4.7. Others
10.5. Market Value Forecast By End User , 2015–2025
10.5.1. Hospitals
10.5.2. Ambulatory Surgical Centers
10.5.3. Ophthalmic Clinics
10.5.4. Homecare Settings
10.6. Market Value Forecast By Country , 2015–2025
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Disease Type
10.7.2. By Formulation Type
10.7.3. By Disease Type
10.7.4. By End User
10.7.5. By Country

11. Europe Ocular Drug Delivery Disease Type Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.1.2. Policies and Regulations
11.1.3. Price Trend Analysis
11.1.4. Key Trends
11.2. Market Value Forecast By Disease Type , 2015–2025
11.2.1. Topical
11.2.2. Ocular Insert
11.2.2.1. Erodible
11.2.2.2. Non-Erodible
11.2.3. Iontophoresis
11.2.4. Intraocular Implant
11.2.4.1. Biodegradable
11.2.4.2. Non-Biodegradable
11.2.5. In Situ Gel & Punctal Plug
11.2.6. Others
11.3. Market Value Forecast By Formulation Type , 2015–2025
11.3.1. Solution
11.3.2. Suspension
11.3.3. Emulsion
11.3.4. Liposomes & Nanoparticles
11.3.5. Ointments
11.4. Market Value Forecast By Disease Type , 2015–2025
11.4.1. Diabetic Retinopathy
11.4.2. Macular Degeneration
11.4.3. Cataract
11.4.4. Glaucoma
11.4.5. Diabetic Macular Edema
11.4.6. Dry Eye Syndrome
11.4.7. Others
11.5. Market Value Forecast By End User , 2015–2025
11.5.1. Hospitals
11.5.2. Ambulatory Surgical Centers
11.5.3. Ophthalmic Clinics
11.5.4. Homecare Settings
11.6. Market Value Forecast By Country , 2015–2025
11.6.1. U.K.
11.6.2. Germany
11.6.3. France
11.6.4. Italy
11.6.5. Russia
11.6.6. Spain
11.6.7. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Disease Type
11.7.2. By Formulation Type
11.7.3. By Disease Type
11.7.4. By End User
11.7.5. By Country

12. Asia Pacific Ocular Drug Delivery Disease Type Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.1.2. Policies and Regulations
12.1.3. Price Trend Analysis
12.1.4. Key Trends
12.2. Market Value Forecast By Disease Type , 2015–2025
12.2.1. Topical
12.2.2. Ocular Insert
12.2.2.1. Erodible
12.2.2.2. Non-Erodible
12.2.3. Iontophoresis
12.2.4. Intraocular Implant
12.2.4.1. Biodegradable
12.2.4.2. Non-Biodegradable
12.2.5. In Situ Gel & Punctal Plug
12.2.6. Others
12.3. Market Value Forecast By Formulation Type , 2015–2025
12.3.1. Solution
12.3.2. Suspension
12.3.3. Emulsion
12.3.4. Liposomes & Nanoparticles
12.3.5. Ointments
12.4. Market Value Forecast By Disease Type , 2015–2025
12.4.1. Diabetic Retinopathy
12.4.2. Macular Degeneration
12.4.3. Cataract
12.4.4. Glaucoma
12.4.5. Diabetic Macular Edema
12.4.6. Dry Eye Syndrome
12.4.7. Others
12.5. Market Value Forecast By End User , 2015–2025
12.5.1. Hospitals
12.5.2. Ambulatory Surgical Centers
12.5.3. Ophthalmic Clinics
12.5.4. Homecare Settings
12.6. Market Value Forecast By Country , 2015–2025
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Disease Type
12.7.2. By Formulation Type
12.7.3. By Disease Type
12.7.4. By End User
12.7.5. By Country

13. Latin America Ocular Drug Delivery Disease Type Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.1.2. Policies and Regulations
13.1.3. Price Trend Analysis
13.1.4. Key Trends
13.2. Market Value Forecast By Disease Type , 2015–2025
13.2.1. Topical
13.2.2. Ocular Insert
13.2.2.1. Erodible
13.2.2.2. Non-Erodible
13.2.3. Iontophoresis
13.2.4. Intraocular Implant
13.2.4.1. Biodegradable
13.2.4.2. Non-Biodegradable
13.2.5. In Situ Gel & Punctal Plug
13.2.6. Others
13.3. Market Value Forecast By Formulation Type , 2015–2025
13.3.1. Solution
13.3.2. Suspension
13.3.3. Emulsion
13.3.4. Liposomes & Nanoparticles
13.3.5. Ointments
13.4. Market Value Forecast By Disease Type , 2015–2025
13.4.1. Diabetic Retinopathy
13.4.2. Macular Degeneration
13.4.3. Cataract
13.4.4. Glaucoma
13.4.5. Diabetic Macular Edema
13.4.6. Dry Eye Syndrome
13.4.7. Others
13.5. Market Value Forecast By End User , 2015–2025
13.5.1. Hospitals
13.5.2. Ambulatory Surgical Centers
13.5.3. Ophthalmic Clinics
13.5.4. Homecare Settings
13.6. Market Value Forecast By Country , 2015–2025
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Disease Type
13.7.2. By Formulation Type
13.7.3. By Disease Type
13.7.4. By End User
13.7.5. By Country

14. Middle East & Africa Ocular Drug Delivery Disease Type Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.1.2. Policies and Regulations
14.1.3. Price Trend Analysis
14.1.4. Key Trends
14.2. Market Value Forecast By Disease Type , 2015–2025
14.2.1. Topical
14.2.2. Ocular Insert
14.2.2.1. Erodible
14.2.2.2. Non-Erodible
14.2.3. Iontophoresis
14.2.4. Intraocular Implant
14.2.4.1. Biodegradable
14.2.4.2. Non-Biodegradable
14.2.5. In Situ Gel & Punctal Plug
14.2.6. Others
14.3. Market Value Forecast By Formulation Type , 2015–2025
14.3.1. Solution
14.3.2. Suspension
14.3.3. Emulsion
14.3.4. Liposomes & Nanoparticles
14.3.5. Ointments
14.4. Market Value Forecast By Disease Type , 2015–2025
14.4.1. Diabetic Retinopathy
14.4.2. Macular Degeneration
14.4.3. Cataract
14.4.4. Glaucoma
14.4.5. Diabetic Macular Edema
14.4.6. Dry Eye Syndrome
14.4.7. Others
14.5. Market Value Forecast By End User , 2015–2025
14.5.1. Hospitals
14.5.2. Ambulatory Surgical Centers
14.5.3. Ophthalmic Clinics
14.5.4. Homecare Settings
14.6. Market Value Forecast By Country , 2015–2025
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East and Africa
14.7. Market Attractiveness Analysis
14.7.1. By Disease Type
14.7.2. By Formulation Type
14.7.3. By Disease Type
14.7.4. By End User
14.7.5. By Country

15. Competition Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis By Company (2015)
15.3. Company Profiles
15.3.1. OCULAR THERAPEUTIX, INC.
15.3.1.1. Overview
15.3.1.2. Financials
15.3.1.3. Recent Developments
15.3.1.4. Strategy
15.3.2. Alimera Sciences
15.3.2.1. Overview
15.3.2.2. Financials
15.3.2.3. Recent Developments
15.3.2.4. Strategy
15.3.3. Allergan, Plc
15.3.3.1. Overview
15.3.3.2. Financials
15.3.3.3. Recent Developments
15.3.3.4. Strategy
15.3.4. Valeant Pharmaceuticals International, Inc. (Bausch & Lomb Incorporated)
15.3.4.1. Overview
15.3.4.2. Financials
15.3.4.3. Recent Developments
15.3.4.4. Strategy
15.3.5. EyeGate Pharma
15.3.5.1. Overview
15.3.5.2. Financials
15.3.5.3. Recent Developments
15.3.5.4. Strategy
15.3.6. Envisia Therapeutics
15.3.6.1. Overview
15.3.6.2. Financials
15.3.6.3. Recent Developments
15.3.6.4. Strategy
15.3.7. Clearside Biomedical, INC.
15.3.7.1. Overview
15.3.7.2. Financials
15.3.7.3. Recent Developments
15.3.7.4. Strategy
15.3.8. Graybug Vision Inc.
15.3.8.1. Overview
15.3.8.2. Financials
15.3.8.3. Recent Developments
15.3.8.4. Strategy
15.3.9. Santen Pharmaceutical Co., Ltd
15.3.9.1. Overview
15.3.9.2. Financials
15.3.9.3. Recent Developments
15.3.9.4. Strategy
15.3.10. Taiwan Liposome Company, Ltd
15.3.10.1. Overview
15.3.10.2. Financials
15.3.10.3. Recent Developments
15.3.10.4. Strategy

List of Table

Table 01: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology Type, 2015–2025
Table 02: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Ocular Inserts, 2015–2025
Table 03: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, Intraocular Implants, 2015–2025
Table 04: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2015–2025
Table 05: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2015–2025
Table 06: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 07: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 08: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 09: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology Type, 2015–2025
Table 10: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Ocular Inserts, 2015–2025
Table 11: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Intraocular Implants, 2015–2025
Table 12: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2015–2025
Table 13: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2015–2025
Table 14: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 15: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 16: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology Type, 2015–2025
Table 17: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Ocular Inserts, 2015–2025
Table 18: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Intraocular Implants, 2015–2025
Table 19: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2015–2025
Table 20: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2015–2025
Table 21: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End Users, 2015–2025
Table 22: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 23: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology Type, 2015–2025
Table 24: Asia Pacific Ocular Drug Delivery Technology Market, by Ocular Inserts, Market Size (US$ Mn) Forecast, 2015–2025
Table 25: Asia Pacific Ocular Drug Delivery Technology Market, by Intraocular Implants, Market Size (US$ Mn) Forecast, 2015–2025
Table 26: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2015–2025
Table 27: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2015–2025
Table 28: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End User, 2015–2025
Table 29: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 30: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology Type, 2015–2025
Table 31: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Ocular Inserts, 2015–2025
Table 32: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Intraocular Implants, 2015–2025
Table 33: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2015–2025
Table 34: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2015–2025
Table 35: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End Users, 2015–2025
Table 36: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 37: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology Type, 2015–2025
Table 38: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Ocular Inserts, 2015–2025
Table 39: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Intraocular Implants, 2015–2025
Table 40: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2015–2025
Table 41: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2015–2025
Table 42: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End-user, 2015–2025

List of Chart

Figure 1: Global Ocular Drug Delivery Technology, Market Size (US$ Mn) Forecast, 2015–2025
Figure 2: Global Ocular Drug Delivery Technology Market Value Share, by Technology Type (2016)
Figure 3: Global Ocular Drug Delivery Technology Market Value Share, by Formulations Type (2016)
Figure 04: Global Ocular Drug Delivery Technology Market Value Share, by Disease Type (2016)
Figure 05: Global Ocular Drug Delivery Technology Market Value Share, by Region (2016)
Figure 06: Global Ocular Drug Delivery Technology Market Value Share, by End-user (2016)
Figure 07: Global Ocular Drug Delivery Technology Market Value Share, by Technology Type, 2017 and 2025
Figure 08: Global Ocular Drug Delivery Technology Market Attractiveness, by Technology Type, 2017–2025
Figure 09: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Topical, 2015–2025
Figure 10: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Ocular Inserts, 2015–2025
Figure 11: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Iontophoresis, 2015–2025
Figure 12: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Intraocular Implants, 2015–2025
Figure 13: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by In Situ Gel & Punctal Plugs, 2015–2025
Figure 14: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Other Technology, 2015–2025
Figure 15: Global Ocular Drug Delivery Technology Market Value Share, by Formulation Type, 2017 and 2025
Figure 16: Global Ocular Drug Delivery Technology Market Attractiveness, by Formulation Type, 2017–2025
Figure 17: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Suspension, 2015–2025
Figure 18: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Solution, 2015–2025
Figure 19: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Liposome & Nanoparticle, 2015–2025
Figure 20: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Emulsion, 2015–2025
Figure 21: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Ointment, 2015–2025
Figure 22: Global Ocular Drug Delivery Technology Market Value Share, by Disease Type, 2017 and 2025
Figure 23: Global Ocular Drug Delivery Technology Market Attractiveness, by Disease Type, 2017–2025
Figure 24: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Glaucoma, 2015–2025
Figure 25: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Diabetic Retinopathy, 2015–2025
Figure 26: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Dry Eye Syndrome, 2015–2025
Figure 27: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Macular Degeneration, 2015–2025
Figure 28: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Diabetic Macular Edema, 2015–2025
Figure 29: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Cataract, 2015–2025
Figure 30: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2015–2025
Figure 31: Global Ocular Drug Delivery Technology Market Value Share, by End-user, 2017 and 2025
Figure 32: Global Ocular Drug Delivery Technology Market Attractiveness, by End-user, 2017–2025
Figure 33: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals, 2015–2025
Figure 34: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by ASCs, 2015–2025
Figure 35: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Ophthalmic Clinics, 2015–2025
Figure 36: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Home Care Settings, 2015–2025
Figure 37: Global Ocular Drug Delivery Technology Market Value Share, by Region, 2017 and 2025 
Figure 38: Global Ocular Drug Delivery Technology Market Attractiveness, by Region, 2017–2025
Figure 39: North America Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 40: North America Ocular Drug Delivery Technology Market Value Share, by Country, 2017 and 2025 
Figure 41: North America Ocular Drug Delivery Technology Market Attractiveness, 2017–2025
Figure 42: North America Ocular Drug Delivery Technology Market Value Share, by Technology Type, 2017 and 2025
Figure 43: North America Ocular Drug Delivery Technology Market Attractiveness, by Technology Type, 2017–2025
Figure 44: North America Ocular Drug Delivery Technology Market Value Share, by Formulation Type, 2017 and 2025
Figure 45: North America Ocular Drug Delivery Technology Market Attractiveness, by Formulation Type, 2017–2025
Figure 46: North America Ocular Drug Delivery Technology Market Value Share, by Disease Type, 2017 and 2025
Figure 47: North America Ocular Drug Delivery Technology Market Attractiveness, by Disease Type, 2017–2025
Figure 48: North America Ocular Drug Delivery Technology Market Value Share, by End-user, 2017 and 2025
Figure 49: North America Ocular Drug Delivery Technology Market Attractiveness, by End-user, 2017–2025
Figure 50: Europe Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 51: Europe Ocular Drug Delivery Technology Market Value Share, by Country, 2017 and 2025 
Figure 52: Europe Ocular Drug Delivery Technology Market Attractiveness, by Country, 2017–2025
Figure 53: Europe Ocular Drug Delivery Technology Market Value Share, by Technology Type, 2017 and 2025
Figure 54: Europe Ocular Drug Delivery Technology Market Attractiveness, by Technology Type, 2017-2025
Figure 55: Europe Ocular Drug Delivery Technology Market Value Share, by Formulation Type, 2017 and 2025
Figure 56: Europe Ocular Drug Delivery Technology Market Attractiveness, by Formulation Type, 2017-2025
Figure 57: Europe Ocular Drug Delivery Technology Market Value Share, by Disease Type, 2017 and 2025
Figure 58: Europe Ocular Drug Delivery Technology Market Attractiveness, by Disease Type, 2017-2025
Figure 59: Europe Ocular Drug Delivery Technology Market Value Share, by End Users, 2017 and 2025
Figure 60: Europe Ocular Drug Delivery Technology Market Attractiveness, by End Users, 2017-2025
Figure 61: Asia Pacific Ocular Drug Delivery Technology, Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2015–2025
Figure 62: Asia Pacific Ocular Drug Delivery Technology Market Value Share, by Country, 2017 and 2025 
Figure 63: Asia Pacific Ocular Drug Delivery Technology, Market Attractiveness, by Country, 2017–2025
Figure 64: Asia Pacific Ocular Drug Delivery Technology Market Value Share, by Technology Type, 2017 and 2025
Figure 65: Asia Pacific Ocular Drug Delivery Technology Market Attractiveness, by Technology Type, 2017-2025
Figure 66: Asia Pacific Ocular Drug Delivery Technology Market Value Share, by Formulation Type, 2017 and 2025
Figure 67: Asia Pacific Ocular Drug Delivery Technology Market Attractiveness, by Formulation Type, 2017-2025
Figure 68: Asia Pacific Ocular Drug Delivery Technology Market Value Share, by Disease Type, 2017 and 2025
Figure 69: Asia Pacific Ocular Drug Delivery Technology Market Attractiveness, by Disease Type, 2017-2025
Figure 70: Asia Pacific Ocular Drug Delivery Technology Market Value Share, by End User, 2017 and 2025
Figure 71: Asia Pacific Ocular Drug Delivery Technology Market Attractiveness, by End User, 2017–2025
Figure 72: Latin America Ocular Drug Delivery Technology, Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2015–2025
Figure 73: Latin America Ocular Drug Delivery Technology Market Value Share, by Country, 2017 and 2025 
Figure 74: Latin America Ocular Drug Delivery Technology, Market Attractiveness, by Country, 2017–2025
Figure 75: Latin America Ocular Drug Delivery Technology Market Value Share, by Technology Type, 2017 and 2025
Figure 76: Latin America Ocular Drug Delivery Technology Market Attractiveness, by Technology Type, 2017-2025
Figure 77: Latin America Ocular Drug Delivery Technology Market Value Share, by Formulation Type, 2017 and 2025
Figure 78: Latin America Ocular Drug Delivery Technology Market Attractiveness, by Formulation Type, 2017–2025
Figure 79: Latin America Ocular Drug Delivery Technology Market Value Share, by Disease Type, 2017 and 2025
Figure 80: Latin America Ocular Drug Delivery Technology  Market Attractiveness, by Disease Type, 2017-2025
Figure 81: Latin America Ocular Drug Delivery Technology Market Value Share, by End Users, 2017 and 2025
Figure 82: Latin America Ocular Drug Delivery Technology Market Attractiveness, by End Users, 2017–2025
Figure 83: Middle East & Africa Ocular Drug Delivery Technology, Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2015–2025
Figure 84: Middle East & Africa Ocular Drug Delivery Technology Market Value Share, by Country, 2017 and 2025 
Figure 85: Middle East & Africa Ocular Drug Delivery Technology, Market Attractiveness, by Country, 2017–2025
Figure 86: Middle East & Africa Ocular Drug Delivery Technology Market Value Share, by Technology Type, 2017 and 2025
Figure 87: Middle East & Africa Ocular Drug Delivery Technology Market Attractiveness, by Technology Type, 2017–2025
Figure 88: Middle East & Africa Ocular Drug Delivery Technology Market Value Share, by Formulation Type, 2017 and 2025
Figure 89: Middle East & Africa Ocular Drug Delivery Technology Market Attractiveness, by Formulation Type, 2017-2025
Figure 90: Middle East & Africa Ocular Drug Delivery Technology Market Value Share, by Disease Type, 2017 and 2025
Figure 91: Middle East & Africa Ocular Drug Delivery Technology Market Attractiveness, by Disease Type, 2017–2025
Figure 92: Middle East & Africa Ocular Drug Delivery Technology Market Value Share, by End-user, 2017 and 2025
Figure 93: Middle East & Africa Ocular Drug Delivery Technology Market Attractiveness, by End-user, 2017–2025
Figure 94: Global Ocular Drug Delivery Technology  Market Share, by Company, 2016

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *